$RNA
Atrium Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$8.16
▲+2.00%+$0.160
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateAtrium Therapeutics, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is RNA up today? It is at $8.16 (+2.00%), and our scanner flagged it 44 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment RNA spikes, and full due diligence on RNA — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $RNA 44 times in the last 30 days. Create a free account to track $RNA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on RNA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystOther Material Event, from the latest SEC filing. Read it →Sources: float & market cap via Polygon · short interest via FINRA · borrow & shortability via Alpaca · SSR from Reg SHO 201 · filings & dilution via SEC EDGAR · analysts via Nasdaq.
Auto-generated from public data for research and education. Not investment advice.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Hoyos Rocio Martin Officer | Sold (automatic/other) | -8K 0.05% of company | sold 18% | 38K | $74K at $8.95 | Sep 18, 26 |
Winslow Brendan R. Officer | Sold (automatic/other) | -7K 0.04% of company | sold 15% | 37K | $60K at $8.95 | Sep 18, 26 |
Gallagher Kathleen P. Officer | Sold (automatic/other) | -12K 0.07% of company | sold 8.9% | 120K | $104K at $8.95 | Sep 18, 26 |
Kenney Stephanie Officer | Sold (automatic/other) | -2K 0.01% of company | sold 6.7% | 33K | $21K at $8.95 | Sep 18, 26 |
Boyce Sarah Director | Sold (automatic/other) | -126K 0.7% of company | sold 48% | 139K | $1.1M at $8.95 | Sep 18, 26 |
Flanagan W. Michael Director | Sold (automatic/other) | -23K 0.1% of company | sold 42% | 32K | $204K at $8.95 | Sep 18, 26 |
Hughes Steven George Officer | Sold (automatic/other) | -21K 0.1% of company | sold 29% | 52K | $192K at $8.95 | Sep 18, 26 |
Younis Husam Officer | Sold (automatic/other) | -11K 0.07% of company | sold 21% | 41K | $100K at $8.95 | Sep 18, 26 |
Younis Husam Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 53K | n/a | Apr 20, 26 |
Hoyos Rocio Martin Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 47K | n/a | Apr 20, 26 |
Gallagher Kathleen P. Officer | Acquired (grant/award) | +103K 0.6% of company | added 100% | 131K | n/a | Apr 20, 26 |
Winslow Brendan R. Officer | Acquired (grant/award) | +30K 0.2% of company | added 100% | 44K | n/a | Apr 20, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on RNA from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for RNA today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
RNA last traded at $8.16, up 2.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Atrium Therapeutics, Inc. Common Stock (RNA) is next expected to report earnings on Thursday, November 12, 2026, about 21 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The RNA Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged RNA 44 times in the last 30 days.
RNA (Atrium Therapeutics, Inc. Common Stock) trades on XNAS, with a market cap of about $137M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge RNA for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$RNA discussion
Sign in to ask a question or join the discussion.